# Juren Capital

Juren Capital is a Private Equity based in Hangzhou, China.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Hangzhou, China
- **Region:** Asia
- **Address:** Hangzhou, China
- **Founded:** 2013
- **Assets under management:** Undisclosed
- **Website:** www.jurencapital.com

## Regulatory record

- **Reports private funds:** No

## About

Zhejiang Juren Capital Management Co., also known as Juren Capital, provides Private Equity investment, Mergers & Acquisition, Strategic Consulting, and Financial Advisement services. The firm has made 14 investments, including a Series B investment in Aomo Pharmaceutical on August 25, 2021. Juren Capital has facilitated 4 portfolio exits, with the most recent being Microtech Medical on October 19, 2021.

## Questions

### What investment stages does Juren Capital target?

The firm operates across the full Chinese venture and growth lifecycle, from seed and start-up rounds through expansion and late-stage growth to pre-IPO placements and PIPE transactions. This multi-stage mandate means the firm can follow portfolio companies from early formation through near-public liquidity events without capping its participation at any single stage boundary.

### How does Hangzhou as a location shape Juren Capital's deal flow?

Hangzhou hosts Alibaba Group's global headquarters, creating a dense ecosystem of technology talent, startup spinouts, and supply-chain financing opportunities across Zhejiang province. For a domestic private equity firm like Juren Capital, proximity to that entrepreneurial density, combined with Hangzhou's cluster of family offices and asset managers, provides access to proprietary or semi-proprietary deal flow in China's eastern technology corridor.

### Is Juren Capital structured as a venture firm or a growth-equity manager?

Juren Capital is structured as a catch-all private equity platform rather than a pure venture or growth-equity manager. Its mandate encompasses seed and venture capital, expansion and late-stage growth, pre-IPO placements, and PIPE transactions. This structure consolidates deployment under a single decision-making framework, distinguishing it from firms that operate separate venture and growth funds with independent teams.

### Who runs investment decisions at Juren Capital?

Publicly available information does not name specific investment committee members or managing partners at Juren Capital. This level of operational opacity is common among private Chinese asset managers, where personnel details and governance structures are rarely disclosed beyond regulatory filings or direct LP relationships.

## Related profiles

- [Junyu Capital](https://altss.com/profile/junyu-capital)
- [Just Eat Ventures](https://altss.com/profile/just-eat-ventures)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/juren-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology